Rare Disease in Oncology

Rare Oncology disease has a mandate to accost the recent challenges presented by rare cancers and diseases as well cancers that may be predominant in medically unreasonable populations. CCR investigators, both at the laboratory bench and in the clinic, are actively involved in this research studies.  In many cases, the knowledge CCR’s investigators gain from studying and treating rare cancer diseases and related disorders provides them with insights into the mechanisms that underlie other more common malignant syndromes.  It is very worthy consideration for oncologists to keep updated of the latest advancements in oncology, as changes in management of cancer are shown quite common. All eligible patients in whom cancer progresses and for whom no general of care treatment strategies are available should be enrolled in a clinical trial.

  • Pediatric Oncology
  • Blood Oncology
  • Merkel-cell carcinoma
  • Cancer and Pharmacology

Related Conference of Rare Disease in Oncology

August 21-23, 2017

3rd Annual Congress on Infectious Diseases

San Francisco, California, USA
September 04-05, 2017

Global Experts Meeting on Sexually Transmitted Diseases

Macau, Hong Kong
September 7-9, 2017

6thEuro-Global Conference on Infectious Diseases

Paris, France
September 13-14, 2017

6th Annual Bacteriology and Parasitology Meeting

Singapore
October 30-November 1, 2017

3rd Annual Congress on Rare Diseases and Orphan Drugs


(10 Plenary Forums - 1 Event)
San Antonio, Texas, USA
March 1-2, 2018

5th International congress on Infectious Diseases

Berlin, Germany

Rare Disease in Oncology Conference Speakers

Recommended Sessions

Related Journals

Are you interested in